Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07513506 · ClinicalTrials.gov registry record · NA
Extensively Hydrolyzed Formula Growth Monitioring Study (GMS)
A NA study, sponsored by Mead Johnson Nutrition.
- Not yet
- Registry status
- NA
- Development phase
- 214
- Enrollment target
NCT07513506: Clinical Trial NA study, sponsored by Mead Johnson Nutrition.
NCT07513506 is a NA study that has not yet begun recruiting, run by Mead Johnson Nutrition. The registered enrollment target is 214 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07513506, a NA study, has not yet begun recruiting, sponsored by Mead Johnson Nutrition.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
Study Summary
This is a research study to compare an investigational infant formula against a currently marketed infant formula. An investigational infant formula is one that has never been approved by the United States Food and Drug Administration (FDA). The purpose of this research study is to evaluate the growth and tolerance of infants who consume a new (not yet available to buy) extensively hydrolyzed cow milk protein infant formula compared to an extensively hydrolyzed cow milk protein infant formula that is currently available to buy. The study will also look at the growth of your baby, how many poops your baby has, what the poops are like (for example, soft or hard), how much study formula your baby drinks, how well your baby handles the study formula (such as spit-up, fussiness, gas, colic, or changes in sleep), and any health problems that might come up during the study.
Interventions
- OTHER Extensively hydrolyzed casein formula (C-eHCF), commercially available
- OTHER Extensively hydrolyzed casein formula (INV-eHCF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2026-04-03 |
| Est. Completion | 2027-05-01 |
| Phase | NA |
What is known before NCT07513506 opens enrollment
NCT07513506 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Extensively hydrolyzed casein formula (C-eHCF), commercially available is the first listed.
NCT07513506 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07513506 about?
NCT07513506 is a clinical study titled "Extensively Hydrolyzed Formula Growth Monitioring Study (GMS)". This is a research study to compare an investigational infant formula against a currently marketed infant formula. An investigational infant formula is one that has never been approved by the United States Food and Drug Administration (FDA). The purpose of this research study is to evaluate the gro...
What is the current status of trial NCT07513506?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 214 participants. The study started on 2026-04-03. Estimated completion is 2027-05-01.
What interventions are being tested in trial NCT07513506?
The interventions under investigation include: Extensively hydrolyzed casein formula (C-eHCF), commercially available (OTHER), Extensively hydrolyzed casein formula (INV-eHCF) (OTHER).
Who is sponsoring clinical trial NCT07513506?
This trial is sponsored by Mead Johnson Nutrition, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07513506's enrollment target sits among peer trials
214 487th of 2000 higher than 1,513 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI